Braveheart Bio, Inc. Common Stock (BRVE) — Net Asset Quality Index
Braveheart Bio, Inc. Common Stock (BRVE) has a Net Asset Quality Index of -95.7% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $81.88 Million minus total liabilities of $160.27 Million yields net assets of $-78.39 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see market cap of Braveheart Bio, Inc. Common Stock.
Quality Index
Net Assets
Total Assets
Total Liabilities
Annual Net Asset Quality Index for Braveheart Bio, Inc. Common Stock (None–None)
The table below presents the year-by-year Net Asset Quality Index for Braveheart Bio, Inc. Common Stock from None to None, covering 0 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Explore debt repayment capacity of Braveheart Bio, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|